title: Epileptic encephalopathies: new genes and new pathways.
abstract: Epileptic encephalopathies represent a group of devastating epileptic disorders that occur early in life and are often characterized by pharmaco-resistant epilepsy, persistent severe electroencephalographic abnormalities, and cognitive dysfunction or decline. Next generation sequencing technologies have increased the speed of gene discovery tremendously. Whereas ion channel genes were long considered to be the only significant group of genes implicated in the genetic epilepsies, a growing number of non-ion-channel genes are now being identified. As a subgroup of the genetically mediated epilepsies, epileptic encephalopathies are complex and heterogeneous disorders, making diagnosis and treatment decisions difficult. Recent exome sequencing data suggest that mutations causing epileptic encephalopathies are often sporadic, typically resulting from de novo dominant mutations in a single autosomal gene, although inherited autosomal recessive and X-linked forms also exist. In this review we provide a summary of the key features of several early- and mid-childhood onset epileptic encephalopathies including Ohtahara syndrome, Dravet syndrome, Infantile spasms and Lennox Gastaut syndrome. We review the recent next generation sequencing findings that may impact treatment choices. We also describe the use of conventional and newer anti-epileptic and hormonal medications in the various syndromes based on their genetic profile. At a biological level, developments in cellular reprogramming and genome editing represent a new direction in modeling these pediatric epilepsies and could be used in the development of novel and repurposed therapies.
authors.affiliation: Departments of Neurology and Pediatrics, University of California, San Francisco, CA, USA, EsmaeeliS@neuropeds.ucsf.edu.
authors.forename: Sahar Esmaeeli
authors.initials: SE
authors.lastname: Nieh
authors.forename: Elliott H
authors.initials: EH
authors.lastname: Sherr
mesh_terms: D001921:Brain / Q000503:physiopathology*; D004831:Epilepsies, Myoclonic / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D004827:Epilepsy / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018887:Landau-Kleffner Syndrome / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D065768:Lennox Gastaut Syndrome / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D017422:Sequence Analysis, DNA; D013036:Spasms, Infantile / Q000175:diagnosis / Q000235:genetics / Q000628:therapy